NO20030528L - Sammensetninger for å forebygge urinveisstein - Google Patents

Sammensetninger for å forebygge urinveisstein

Info

Publication number
NO20030528L
NO20030528L NO20030528A NO20030528A NO20030528L NO 20030528 L NO20030528 L NO 20030528L NO 20030528 A NO20030528 A NO 20030528A NO 20030528 A NO20030528 A NO 20030528A NO 20030528 L NO20030528 L NO 20030528L
Authority
NO
Norway
Prior art keywords
compositions
urinary tract
prevent urinary
tract stones
stones
Prior art date
Application number
NO20030528A
Other languages
English (en)
Other versions
NO20030528D0 (no
Inventor
Yasunori Yoshida
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of NO20030528L publication Critical patent/NO20030528L/no
Publication of NO20030528D0 publication Critical patent/NO20030528D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/244Lanthanides; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/04Drugs for disorders of the urinary system for urolithiasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20030528A 2000-08-04 2003-02-03 Sammensetninger for å forebygge urinveisstein NO20030528D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000237329A JP2002047210A (ja) 2000-08-04 2000-08-04 尿路結石防止用組成物
PCT/JP2001/005125 WO2002011770A1 (fr) 2000-08-04 2001-06-15 Compositions pour la prevention des calculs urinaires

Publications (2)

Publication Number Publication Date
NO20030528L true NO20030528L (no) 2003-02-03
NO20030528D0 NO20030528D0 (no) 2003-02-03

Family

ID=18729211

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030528A NO20030528D0 (no) 2000-08-04 2003-02-03 Sammensetninger for å forebygge urinveisstein

Country Status (11)

Country Link
US (1) US20030186845A1 (no)
EP (1) EP1323433A1 (no)
JP (1) JP2002047210A (no)
KR (1) KR20030016421A (no)
AU (1) AU2001264295A1 (no)
CA (1) CA2416531A1 (no)
IL (1) IL153693A0 (no)
NO (1) NO20030528D0 (no)
NZ (1) NZ523778A (no)
TW (1) TW570806B (no)
WO (1) WO2002011770A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465465B2 (en) 2003-08-26 2008-12-16 Shire Biochem Inc. Pharmaceutical formulation comprising lanthanum compounds
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
US20070264200A1 (en) * 2005-11-14 2007-11-15 Scott Small Mouse MRI for drug screening
CN111175360B (zh) * 2020-02-24 2022-03-04 扬州工业职业技术学院 一种基于二次聚合的苏丹红-i分子印迹传感器的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056427A1 (fr) * 1997-06-12 1998-12-17 Mitsubishi Chemical Corporation Agent de contrast

Also Published As

Publication number Publication date
NZ523778A (en) 2004-07-30
TW570806B (en) 2004-01-11
IL153693A0 (en) 2003-07-06
KR20030016421A (ko) 2003-02-26
CA2416531A1 (en) 2002-02-14
AU2001264295A1 (en) 2002-02-18
NO20030528D0 (no) 2003-02-03
EP1323433A1 (en) 2003-07-02
JP2002047210A (ja) 2002-02-12
US20030186845A1 (en) 2003-10-02
WO2002011770A1 (fr) 2002-02-14

Similar Documents

Publication Publication Date Title
ATE476975T1 (de) Abführende zusammensetzungen
ATE303787T1 (de) Schergelzusammensetzungen
DK1294644T3 (da) Vandbehandlingssammensætninger
IS2932B (is) Fúlvestrant samsetning
HUP0100586A3 (en) Pharmaceutical compositions treating lower urinary tract symptoms
DE60143178D1 (de) Lichtempfindliche Zusammensetzung
AR028197A1 (es) Composiciones antitranspirantes
AR028320A1 (es) Nuevas composiciones de antihelminticos
DE60128818D1 (de) Antireflexionszusammensetzung
DE50113647D1 (de) IR-absorbierende Zusammensetzungen
DE60000944T2 (de) Bohrlochzementzusammensetzungen
DE60108136D1 (de) Benzinzusammensetzung
DE60223654D1 (de) Resistzusammensetzung
AU2877102A (en) Small molecule compositions for binding to hsp90
ATE372372T1 (de) Zusammensetzungen enthaltend cyclodextrin
DE60100567D1 (de) Antimikrobielle zusammensetzungen
PT1250321E (pt) Composicao de gliburida
DE60025624D1 (de) Farbstabile polyarylat enthaltende zusammensetzungen
ATE369830T1 (de) Schweisshemmende zusammensetzungen
FR2831433B1 (fr) Composition topique solide
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE60139499D1 (de) Reinigungsmittelzusammensetzungen
DE60116858D1 (de) Zusammensetzung
DE60126423D1 (de) Wasserlösliche fixierwachszusammensetzung
NO20013891D0 (no) Sammensetninger omfattende citalopram

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application